Very-low-density lipoprotein of uremic patients is a poor substrate for bovine lipoprotein lipase in vitro

被引:12
作者
Amadottir, M
Dallongeville, J
Fruchart, JC
NilssonEhle, P
机构
[1] UNIV LUND HOSP, DEPT NEPHROL, S-22185 LUND, SWEDEN
[2] UNIV LUND HOSP, DEPT CLIN CHEM, S-22185 LUND, SWEDEN
[3] INST PASTEUR, INSERM U325, F-59019 LILLE, FRANCE
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 1996年 / 45卷 / 06期
关键词
D O I
10.1016/S0026-0495(96)90132-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Very-low-density lipoprotein (VLDL) from 10 hemodialysis patients and 10 healthy controls was studied with respect to the substrate characteristics for bovine milk lipoprotein lipase (LPL). Compared with the control subjects, the hemodialysis patients had significantly higher serum triglyceride and apolipoprotein B-associated apolipoprotein CIII concentrations (1.03 +/- 0.31 v 1.98 +/- 0.86 mmol/L and 0.004 +/- 0.002 v 0.011 +/- 0.005 g/L, respectively), lower serum high-density lipoprotein (HDL) cholesterol and apolipoprotein Al concentrations (1.33 +/- 0.37 v 0.95 +/- 0.31 mmol/L and 1.29 +/- 0.25 v 1.09 +/- 0.23 g/L, respectively), and lower postheparin plasma LPL activity (82 +/- 24 v 35 +/- 14 mU/mL). There were also significant increases in the relative fat content and diameter of VLDL particles from patients versus controls. VLDL was labeled with a fluorescent phospholipid analog, DHPE, and the rate of the lipolytic reaction with purified bovine milk LPL was estimated from the increase in fluorescence intensity at 490 nm. There was no significant difference between initial reaction velocities in the study groups, but VLDL particles from hemodialysis patients were lipolyzed to a significantly lesser extent than those from healthy controls (mean increase in fluorescence intensity after completion of the reaction, 95 +/- 36 v 140 +/- 43 arbitrary units). These results are in accordance with the accumulation of remnant particles reported to occur in uremia despite only a moderately increased serum triglyceride concentration. Copyright (C) 1996 by W.B. Saunders Company.
引用
收藏
页码:686 / 690
页数:5
相关论文
共 23 条
[1]  
ATGER V, 1989, ANN BIOL CLIN-PARIS, V47, P497
[2]   ANOMALIES IN COMPOSITION OF UREMIC LIPOPROTEINS ISOLATED BY GRADIENT ULTRACENTRIFUGATION - RELATIVE ENRICHMENT OF HDL IN APOLIPOPROTEIN C-III AT THE EXPENSE OF APOLIPOPROTEIN A-I [J].
ATGER, V ;
DUVAL, F ;
FROMMHERZ, K ;
DRUEKE, T ;
LACOUR, B .
ATHEROSCLEROSIS, 1988, 74 (1-2) :75-83
[3]   SERUM APOLIPOPROTEIN PROFILE OF PATIENTS WITH CHRONIC-RENAL-FAILURE [J].
ATTMAN, PO ;
ALAUPOVIC, P ;
GUSTAFSON, A .
KIDNEY INTERNATIONAL, 1987, 32 (03) :368-375
[4]   PLASMA HIGH-DENSITY LIPOPROTEIN CONCENTRATIONS IN CHRONIC-HEMODIALYSIS AND RENAL-TRANSPLANT PATIENTS [J].
BAGDADE, JD ;
ALBERS, JJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1977, 296 (25) :1436-1439
[5]   INTERACTION OF LIPOPROTEIN-LIPASE WITH HEPARIN-SEPHAROSE - EVALUATION OF CONDITIONS FOR AFFINITY BINDING [J].
BENGTSSON, G ;
OLIVECRONA, T .
BIOCHEMICAL JOURNAL, 1977, 167 (01) :109-119
[6]   PREVALENCE OF SERUM-LIPID ABNORMALITIES IN CHRONIC-HEMODIALYSIS [J].
BRUNZELL, JD ;
ALBERS, JJ ;
HAAS, LB ;
GOLDBERG, AP ;
AGADOA, L ;
SHERRARD, DJ .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1977, 26 (08) :903-910
[7]  
CAMEJO G, 1988, BIOMED BIOCHIM ACTA, V47, P239
[8]   PATHOGENIC ROLES OF POST-HEPARIN LIPASES IN LIPID ABNORMALITIES IN HEMODIALYSIS-PATIENTS [J].
CHAN, MK ;
PERSAUD, J ;
VARGHESE, Z ;
MOORHEAD, JF .
KIDNEY INTERNATIONAL, 1984, 25 (05) :812-818
[9]   HEPARIN-RELEASED PLASMA LIPASES IN CHRONIC RENAL-FAILURE AND AFTER RENAL-TRANSPLANTATION [J].
CRAWFORD, GA ;
SAVDIE, E ;
STEWART, JH .
CLINICAL SCIENCE, 1979, 57 (02) :155-165
[10]   CHANGES IN PLASMA HIGH-DENSITY LIPOPROTEINS IN CHRONIC MALE ALCOHOLICS DURING AND AFTER ABUSE [J].
DANIELSSON, B ;
EKMAN, R ;
FEX, G ;
JOHANSSON, BG ;
KRISTENSSON, H ;
NILSSONEHLE, P ;
WADSTEIN, J .
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1978, 38 (02) :113-119